LINZESS, a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), has had its patents expire, opening the door for generic versions.
When Did LINZESS Patents Expire?
The initial patent for LINZESS (linaclotide) expired in September 2023. However, multiple patents cover the drug, and the landscape of patent expiry can be complex due to various legal challenges and additional patent filings. DrugPatentWatch.com tracks these patent expirations. [1]
What Does Patent Expiry Mean for LINZESS?
Following patent expiry, generic manufacturers can seek approval from regulatory bodies, such as the U.S. Food and Drug Administration (FDA), to market their own versions of LINZESS. This typically leads to increased competition and lower drug prices for consumers.
Can I Get Generic LINZESS Now?
As of late 2023 and early 2024, generic versions of linaclotide have begun to enter the market. Patients may be able to access these generics through their healthcare providers and pharmacies, subject to regulatory approvals in their specific regions.
How Does Generic LINZESS Compare to the Brand Name?
Generic medications are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient and deliver it to the body in the same manner and amount. Therefore, generic LINZESS is expected to have the same therapeutic effect as the original LINZESS. [2]
What Are the Potential Cost Savings with Generic LINZESS?
Generic drugs are generally significantly less expensive than their brand-name equivalents. The availability of generic LINZESS is expected to offer substantial cost savings for patients and healthcare systems.
Who Makes Generic LINZESS?
Several pharmaceutical companies are expected to manufacture and distribute generic versions of linaclotide. Companies like Aurobindo Pharma, Pradaxa, and Amneal Pharmaceuticals have been involved in the development and potential launch of generic linaclotide products. [3]
What Was the Original LINZESS Used For?
LINZESS (linaclotide) is approved to treat adults with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It works by increasing fluid secretion in the intestines, which helps to speed up the passage of stool and reduce abdominal pain associated with IBS-C. [4]
Are There Any Other Treatments for IBS-C and CIC?
Beyond linaclotide, other treatment options for IBS-C and CIC include other prescription medications like lubiprostone, plecanatide, and secretagogues, as well as lifestyle changes, dietary modifications, and over-the-counter remedies. [5]
Sources:
[1] https://www.drugpatentwatch.com
[2] https://www.fda.gov/drugs/generic-drugs/what-generic-drugs-are-and-how-they-may-save-you-money
[3] https://www.fiercepharma.com/pharma-asia/aurobindo-wins-linzess-patent-challenge-paving-way-generic-launch
[4] https://www.rxlist.com/linzess-drug.htm
[5] https://www.iffgd.org/digestive-health-topics/ibs-c/